CAS RN: 601-34-3

Cholesterol Palmitate

Product Availability

Choose a grade to view its available package options.

3 package records0 with current stock1 grade group
Batch No.PackageAvailabilityInquiry
Batchno.20260308 100g Out of stock Inquiry
Batchno.20250331 25g Out of stock Inquiry
Batchno.20250311 5g Out of stock Inquiry
  • Product code: SSC-168672
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 25g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 601-34-3
Pack Size Recorded Purity Available Qty Ship From Inquiry
25g ≥95% 0 Out of Stock Beijing Inquiry

601-34-3 / [(9S,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hexadecanoate

Standard CAS: 601-34-3 Multi CAS: Yes

Basic Information

CAS
601-34-3
Multi CAS
Yes
Molecular Formula
C43H76O2
Molecular Weight
625.100000
Exact Mass
624.584532
InChI
InChI=1S/C43H76O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-23-41(44)45-36-28-30-42(5)35(32-36)24-25-37-39-27-26-38(34(4)22-20-21-33(2)3)43(39,6)31-29-40(37)42/h24,33-34,36-40H,7-23,25-32H2,1-6H3/t34-,36?,37?,38-,39+,40+,42?,43?/m1/s1
InChIKey
BBJQPKLGPMQWBU-YZDFYKTKSA-N

Computed Properties

Structural Parameters

Heavy atom count
45
Fraction Csp3
0.93
Rotatable bonds
20
H-bond acceptors
2
Molar refractivity
193.24
TPSA
26.3

LogP / Solubility

WLOGP
13.42
MLOGP
11.86
XLogP3
16.4
Consensus LogP
13.89
Log S (ESOL)
-10.85
Class (ESOL)
Insoluble
Log S (Ali)
-14.38
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-17.26
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
3

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
8.5

Get In Touch

Contact Us